Figures & data
Table 1. Characteristics of the respondents.
Figure 1. Percentage of gynecologic oncologists (blue) and gynecologists (red) who agree/strongly agree that estrogen replacement therapy (ERT) is contraindicated (no ERT), prescribe systemic ERT or local estrogen therapy. Non-significant differences between gynecologic oncologists and gynecologists (Fisher’s exact test).
![Figure 1. Percentage of gynecologic oncologists (blue) and gynecologists (red) who agree/strongly agree that estrogen replacement therapy (ERT) is contraindicated (no ERT), prescribe systemic ERT or local estrogen therapy. Non-significant differences between gynecologic oncologists and gynecologists (Fisher’s exact test).](/cms/asset/ed851592-2e83-451b-9824-424fc6a4d2ba/iups_a_1544597_f0001_c.jpg)
Figure 2. Percentage of gynecologic oncologists (blue) and gynecologists (red) who agree/strongly agree that estrogen replacement therapy (ERT) is contraindicated (no ERT) and drug of choice in the high-risk endometrial case. *p = 0.039; **p = 0.011 (Fisher’s exact test).
![Figure 2. Percentage of gynecologic oncologists (blue) and gynecologists (red) who agree/strongly agree that estrogen replacement therapy (ERT) is contraindicated (no ERT) and drug of choice in the high-risk endometrial case. *p = 0.039; **p = 0.011 (Fisher’s exact test).](/cms/asset/2cd495c1-4fd8-4d27-b457-c81f8ca0ec47/iups_a_1544597_f0002_c.jpg)
Table 2. Comparison of prescription intentions between Swedish, Japanese, and German doctors.